Mylan Access medicine
We believe every American deserves the opportunity to live a healthy life. See how Mylan is making a difference.

That makes our mission very personal. After all, everyone we’re trying to reach is somebody’s friend, neighbor or family member, including our own. In fact, our quality products probably are in your medicine cabinet now.

Substantial U.S. Savings

$265 billion

in savings from generics in 2017

~$20.4 billion

in savings from Mylan generics in 2017

In 2017, generics filled 90% of all prescriptions dispensed in the U.S., saving our healthcare system billions of dollars. Mylan knows people are concerned about the price of prescription drugs.

So are we.

Medicines You Need

Mylan offers medicines that address a range of health concerns around the U.S. from the common cold to serious diseases like cancer, autoimmune disorders, diabetes, respiratory conditions and Alzheimer’s.

Mylan launched more generics than any other company
in the last 5 years.

2nd largest provider
of prescriptions dispensed in the U.S.

>650 branded, generic and OTC products
offered in the U.S.

Not only is Mylan a leader in the fight against many of our nation’s most prevalent diseases, we filled more prescriptions in 2016 than AstraZeneca, GSK, Johnson & Johnson, Lilly, Merck, Pfizer and Sanofi COMBINED

1 in 3 women

in the U.S. will fight cancer in their lifetime.1

Mylan is one of the largest suppliers of cancer medicines in the U.S.2

16M people

in the U.S. are living with COPD3

Mylan is a provider of branded and generic COPD medicines in the U.S.


people receive ARV treatments in developing countries.

>40% of all patients globally being treated for HIV/AIDS depend on a Mylan product.


people are managing their diabetes in the U.S.4

Mylan is a leading provider of oral diabetes medicine in the U.S.2

The majority of Mylan’s doses sold in America are manufactured in America.*

*Manufactured from domestic and imported components

Mylan has one of the industry’s broadest pipelines with >200 applications pending approval at FDA

In the last five years,
Mylan launched more generics than any other company.